口内乾燥症(Xerostomia):治療薬開発パイプライン動向2015

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DELVP501746)
◆英語タイトル:Xerostomia-Pipeline Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DELVP501746
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:60以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥140,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[口内乾燥症(Xerostomia):治療薬開発パイプライン動向2015]についてメールでお問い合わせはこちら
本調査レポートでは、世界における口内乾燥症(Xerostomia)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の製品リスト等をお届けしています。また、口内乾燥症(Xerostomia)治療薬開発に取り組んでいる企業情報も提供しています。(※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。)

・口内乾燥症(Xerostomia)の概要

・口内乾燥症(Xerostomia)のパイプライン製品概要

・企業別開発中の治療薬

・後期治験段階の製品(Filed & Phase III):比較分析

・中期治験段階の製品(Phase II):比較分析

・初期治験段階の製品(Phase I & IND):比較分析

・前臨床段階の製品:比較分析

・薬剤候補のプロファイル

・口内乾燥症(Xerostomia)治療薬の評価
  - 単剤治療薬
  - 併用治療薬
  - 投与経路別
  - 分子の種類別

・開発が中止された製品リスト

・開発休止中の製品リスト

・口内乾燥症(Xerostomia)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s,“ Xerostomia-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Xerostomia. This report provides information on the therapeutic development based on the Xerostomia dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of Xerostomia
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Xerostomia pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Xerostomia and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Xerostomia Overview
• Xerostomia Pipeline Therapeutics
• Xerostomia Therapeutics under Development by Companies
• Xerostomia Late Stage Products (Filed and Phase III)
– Comparative Analysis
• Xerostomia Mid Clinical Stage Products (Phase II)
– Comparative Analysis
• Xerostomia Early Clinical Stage Products (Phase I and IND Filed)
– Comparative Analysis
• Xerostomia Discovery and Pre-Clinical Stage Products
– Comparative Analysis
• Drug Candidate Profiles
• Xerostomia – Therapeutics Assessment
– Assessment by Monotherapy Products
– Assessment by Combination Products
– Assessment by Route of Administration
– Assessment by Molecule Type
• Xerostomia – Discontinued Products
• Xerostomia – Dormant Products
• Companies Involved in Therapeutics Development for Xerostomia
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Xerostomia, 2015
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2015
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2015
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2015
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2015
• Drug Candidates Profiles
• Xerostomia Assessment by Monotherapy Products
• Xerostomia Assessment by Combination Products
• Xerostomia Assessment by Route of Administration
• Xerostomia Assessment by Stage and Route of Administration
• Xerostomia Assessment by Molecule Type
• Xerostomia Assessment by Stage and Molecule Type
• Xerostomia Therapeutics – Discontinued Products
• Xerostomia Therapeutics – Dormant Products
• Products under Development by Companies, 2015


List of Figures
• Number of Products under Development for Xerostomia, 2015
• Late Clinical Stage Products (Filed and Phase III), 2015
• Mid Clinical Stage Products (Phase II), 2015
• Early Clinical Stage Products (Phase I and IND Filed), 2015
• Discovery and Pre-Clinical Stage Products, 2015
• Xerostomia Assessment by Monotherapy Products
• Xerostomia Assessment by Combination Products
• Xerostomia Assessment by Route of Administration
• Xerostomia Assessment by Stage and Route of Administration
• Xerostomia Assessment by Molecule Type
• Xerostomia Assessment by Stage and Molecule Type


*** レポートのキーワード ***

口内乾燥症(Xerostomia)、治療薬(医薬品、薬剤)、製薬企業、研究開発、治験、製品パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • キセノンテストチャンバーの世界市場予測2018-2023
    Xenon test chamber is affordable, full-featured, and has a large specimen capacity. It provides precise control of critical test parameters including spectrum, irradiance, relative humidity, chamber temperature and black standard temperature. Xenon test chamber is used for the selection of new mater …
  • TDI – New England Clean Power Link – Vermont:建設プロジェクト概要
    World Market Intelligence's "TDI – New England Clean Power Link – Vermont - Construction Project Profile" is a crucial resource for industry executives and anyone looking to access key information about the TDI – New England Clean Power Link – Vermont construction project. World Market Intelligence' …
  • 研究施設建設市場レポート:アイルランド
    This report is the result of Timetric’s extensive market research covering the research facilities construction industry in Ireland. It contains detailed historic and forecast market value data for the research facilities construction industry, including a breakdown of the data by construction activ …
  • 複合発電システムの世界市場2021
    Notes:Production, means the output of Hybrid Power System Revenue, means the sales value of Hybrid Power System This report studies Hybrid Power System in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with P …
  • サウジアラビアのメイクアップ製品市場インサイト
    SummaryHigh disposable income and significant proportion of young population will drive the demand for consumer goods market in Saudi Arabia. In the Saudi Arabian Make-Up market, Face Make-Up is the largest category in value terms, while Nail Make-Up category is forecast to gain maximum market share …
  • NVH(システム・部品・材料)の世界市場2016
    Notes:Production, means the output of NVH (System, Parts, Materials) Revenue, means the sales value of NVH (System, Parts, Materials) This report studies NVH (System, Parts, Materials) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manuf …
  • 出版紙の世界及び中国市場 2018年
    The 'Global and Chinese Publishing Paper Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Publishing Paper industry with a focus on the Chinese market. The report provides key statistics on the market status of the Publishing Paper m …
  • 錫青銅の世界市場
    In this report, the global Tin Bronze market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (milli …
  • オーストリアの澱粉製品市場(~2019)
    The report Starch Product Market in Austria to 2019 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for starch products in Austria. The research includes historic data from 2008 to 2014 and forecasts until 2019 whi …
  • 民間航空機向けビデオ監視システムの世界市場:コックピットドア監視システム、客室(キャビン)監視システム、陸上操縦カメラシステム
    About Commercial Aircraft Video Surveillance Safety and security of both passengers and aircrafts is one of the top priorities of airline operators. Aircraft video surveillance systems are used for monitoring the activities in the cockpit, cabin areas, cargo areas, and on the ground so that the crew …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DELVP501746 )"口内乾燥症(Xerostomia):治療薬開発パイプライン動向2015" (英文:Xerostomia-Pipeline Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。